Cover Image

Panniculitis Associated with MEK Inhibitor Therapy: An Uncommon Adverse Effect

The combination of MEK inhibitor (cobimetinib, trametinib) and BRAF inhibitor (vemurafenib, dabrafenib) is now the first-line treatment in patients with BRAF V600-mutated metastatic melanoma. This association reduces cutaneous adverse events induced by BRAF inhibitors alone, including photosensitivi...

Full description

Saved in:
Bibliographic Details
Main Authors: Miruna Negulescu (Author), Florian Deilhes (Author), Vincent Sibaud (Author), Emilie Tournier (Author), Laurence Lamant (Author), Serge Boulinguez (Author), Nicolas Meyer (Author)
Format: Book
Published: Karger Publishers, 2017-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items